Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/05/1995 | EP0646172A1 Recombinant entomopoxvirus |
04/05/1995 | EP0646171A1 Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes |
04/05/1995 | EP0646170A1 DIABETOGENE $i(rad): A TYPE II DIABETES SPECIFIC GENE |
04/05/1995 | EP0646165A1 Detergent compositions containing lipase and water-soluble quaternary ammonium compounds |
04/05/1995 | EP0646129A1 Receptor-type tyrosine kinase-like molecules |
04/05/1995 | EP0646124A1 A genetically engineered cell line for detecting infectious herpes simplex virus and method therefor |
04/05/1995 | EP0646015A1 Contraceptive vaccine |
04/05/1995 | EP0646013A1 Platelet derived growth factor antagonists |
04/05/1995 | EP0646010A1 Use of mullerian inhibiting substance for treating tumors and for modulating class 1 major histocompatibility antigen expression |
04/05/1995 | EP0549675B1 Detergent containing protease and inhibitor and novel inhibitors for use therein |
04/05/1995 | EP0513161B1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
04/05/1995 | EP0507839B1 Method of separating haemopoietic progenitor cells |
04/05/1995 | EP0318554B1 Targeted multifunctional proteins |
04/05/1995 | EP0277212B1 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor |
04/05/1995 | EP0180615B1 Novel atrial natriuretic/vasodilator polypeptides |
04/05/1995 | CN1101208A Novel cell cortex protein |
04/05/1995 | CN1101074A Dimeric single colony stimulating factor |
04/05/1995 | CN1028114C Monoclonal antibody specific for adhesion function domain of phagocyte surface protein |
04/04/1995 | US5403924 Taga gene and methods for detecting predisposition to peptic ulceration |
04/04/1995 | US5403918 Fatty acyl reductase |
04/04/1995 | US5403915 Isolation and purification of lung surfactant protein |
04/04/1995 | US5403737 Serine protease variants having peptide ligase activity |
04/04/1995 | US5403734 t-PA with growth factor domain substitutions |
04/04/1995 | US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label |
04/04/1995 | US5403712 Transcription cofactor assay |
04/04/1995 | US5403711 Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled nucleic acid probe is cleaved |
04/04/1995 | US5403710 Nucleic acid probes and methods for detecting pathogenic candida yeasts |
04/04/1995 | US5403709 Method for sequencing synthetic oligonucleotides containing non-phosphodiester internucleotide linkages |
04/04/1995 | US5403582 Vaccine comprising fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus |
04/04/1995 | US5403581 Administering immunogenic polypeptide to poultry |
04/04/1995 | US5403484 Viruses expressing chimeric binding proteins |
04/04/1995 | CA1335081C Expression system comprising aspergillus niger pectin lyase i gene sequences |
04/04/1995 | CA1335070C Dna amplification and subtraction techniques |
04/03/1995 | EP0672152A4 Fusion proteins comprising mgf and il-3. |
03/31/1995 | CA2132937A1 Protein expression system |
03/30/1995 | WO1995008647A1 METHOD FOR CONSTRUCTION OF NORMALIZED cDNA LIBRARIES |
03/30/1995 | WO1995008646A1 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood |
03/30/1995 | WO1995008645A1 Isolation and composition of novel glycosidases |
03/30/1995 | WO1995008644A1 Self-sustained sequence replication electrochemiluminescent nucleic acid assay |
03/30/1995 | WO1995008642A1 Nucleic acid detection with energy transfer |
03/30/1995 | WO1995008641A1 Wilson disease gene |
03/30/1995 | WO1995008635A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof |
03/30/1995 | WO1995008634A1 Method for generating influenza a viruses bearing attenuating mutations in internal protein genes |
03/30/1995 | WO1995008633A1 Plant genetic manipulation |
03/30/1995 | WO1995008632A1 Immunoreactive antigens of hepatitis e virus |
03/30/1995 | WO1995008631A2 Target antigens of transmission blocking antibodies for malaria parasites |
03/30/1995 | WO1995008630A1 Surface loop structural analogues of fibroblast growth factors |
03/30/1995 | WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof |
03/30/1995 | WO1995008628A2 Nucleic acids encoding merosin, merosin fragments and uses thereof |
03/30/1995 | WO1995008627A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds |
03/30/1995 | WO1995008625A1 Mammalian cloning by embryonic stem cell (esc) nuclear transplantation and esc |
03/30/1995 | WO1995008624A1 HUMAN PHOSPHOLIPASE C-α AND DNA SEQUENCE CODING FOR THE SAME |
03/30/1995 | WO1995008622A1 Recombinant infectious laryngotracheitis virus and uses thereof |
03/30/1995 | WO1995008573A1 Peptide having antithrombotic activity and process for producing the same |
03/30/1995 | WO1995008570A1 Chimeric proteins which block complement activation |
03/30/1995 | WO1995008569A1 NOVEL PROTEIN sp38 AND CONTRACEPTIVE VACCINE |
03/30/1995 | WO1995008565A1 Use of angiotensin ii analogs in tissue repair |
03/30/1995 | WO1995008554A1 Nf-at polypeptides and polynucleotides |
03/30/1995 | WO1995008548A1 Recombinant production of novel polyketides |
03/30/1995 | WO1995008350A1 REGULATION OF bcl-2 GENE EXPRESSION |
03/30/1995 | WO1995008347A1 Methods and products for controlling immune responses in mammals |
03/30/1995 | WO1995008346A1 A method for the biological control of pollen in plants |
03/30/1995 | WO1995008343A1 Modified truncated complement system regulators |
03/30/1995 | WO1995005472A3 Processes for producing polyhydroxybutyrate and related polyhydroxyalkanoates in the plastids of higher plants |
03/30/1995 | WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
03/30/1995 | WO1995002694A3 Materials and methods for the control of calliphoridae pests |
03/30/1995 | WO1995000852A3 A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130 |
03/30/1995 | WO1994029467A3 Methods and compositions for modulating lipid content of plant tissues |
03/30/1995 | WO1994028153A3 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
03/30/1995 | WO1994024279A3 Agents for the prevention and treatment of huntington's disease and other neurological disorders |
03/30/1995 | CA2172610A1 Chimeric proteins which block complement activation |
03/30/1995 | CA2172540A1 Method for the biological control of pollen in plants |
03/30/1995 | CA2172504A1 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood |
03/30/1995 | CA2172494A1 Use of angiotensin ii analogs in tissue repair |
03/30/1995 | CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof |
03/30/1995 | CA2172387A1 Recombinant infectious laryngotracheitis virus and uses thereof |
03/30/1995 | CA2172385A1 Nucleic acids encoding merosin, merosin fragments and uses thereof |
03/30/1995 | CA2172287A1 Nf-at polypeptides and polynucleotides |
03/30/1995 | CA2172073A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof |
03/30/1995 | CA2171629A1 Recombinant production of novel polyketides |
03/30/1995 | CA2171206A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds |
03/30/1995 | CA2170521A1 Immunoreactive antigens of hepatitis e virus |
03/30/1995 | CA2169620A1 Retargeting antibodies |
03/29/1995 | EP0645460A2 Detection of Yersinia intermedia |
03/29/1995 | EP0645455A1 Acetobacter, plasmid originating therein, and shuttle vector constructed from said plasmid |
03/29/1995 | EP0645453A2 Alcohol de hydrogenase, DNA encoding it, preparation and method of preparing optically active alcohols |
03/29/1995 | EP0645452A1 Human interferon-beta 2A and interfeon-beta 2B, vectors containing genes coding for said interferons, cell lines producing same and use of said interferons as pharmaceuticals |
03/29/1995 | EP0645451A1 Heparin binding site structural analogues of fibroblast growth factors |
03/29/1995 | EP0645450A1 Human calcitonin precursor polyprotein structural gene |
03/29/1995 | EP0645449A1 Method for specific cloning of nucleic acids |
03/29/1995 | EP0645094A1 Improvement of gas and alcohol production by yeast |
03/29/1995 | EP0644948A1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor |
03/29/1995 | EP0644947A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
03/29/1995 | EP0644946A1 Vector particles resistant to inactivation by human serum |
03/29/1995 | EP0644945A1 Pretreatment of microprojectiles prior to using in a particle gun |
03/29/1995 | EP0644944A1 Adeno-associated virus with inverted terminal repeat sequences as promoter |
03/29/1995 | EP0644943A1 Maintenance of male-sterile plants |
03/29/1995 | EP0644942A1 Co-ordinated inhibition of plant gene expression |
03/29/1995 | EP0644941A1 cDNA CLONING OF INOSITOL MONOPHOSPHATASE |
03/29/1995 | EP0644940A1 PROCESS FOR ENZYMATIC PREPARATION OF -i(S)-6-METHOXY-A-METHYL-2-MAPHTHALENEACETIC ACID |